Caricamento...
Growth Hormone Control of Hepatic Lipid Metabolism
In humans, low levels of growth hormone (GH) and its mediator, IGF-1, associate with hepatic lipid accumulation. In mice, congenital liver-specific ablation of the GH receptor (GHR) results in reductions in circulating IGF-1 and hepatic steatosis, associated with systemic insulin resistance. Due to...
Salvato in:
| Pubblicato in: | Diabetes |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Diabetes Association
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5127251/ https://ncbi.nlm.nih.gov/pubmed/27679560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db16-0649 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|